Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2003. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1461051018 | Lisinopril (substance) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 1480987013 | Lisinopril | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lisinopril | Is a | Substance with angiotensin-converting enzyme inhibitor mechanism of action | true | Inferred relationship | Existential restriction modifier | ||
| Lisinopril | Has disposition | Angiotensin-converting enzyme inhibitor | true | Inferred relationship | Existential restriction modifier | ||
| Lisinopril | Is a | Chemical categorized functionally | false | Inferred relationship | Existential restriction modifier | ||
| Lisinopril | Is a | Dipeptide | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Lisinopril 10mg tablets (Crescent Pharma Ltd) 28 tablet 2 x 14 tablets | Has specific active ingredient | True | Lisinopril | Inferred relationship | Existential restriction modifier | |
| Lisinopril 20mg tablets (Crescent Pharma Ltd) 28 tablet 2 x 14 tablets | Has basis of strength substance | True | Lisinopril | Inferred relationship | Existential restriction modifier | 1 |
| Lisinopril 20mg tablets (Crescent Pharma Ltd) 28 tablet 2 x 14 tablets | Has specific active ingredient | True | Lisinopril | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR